Literature DB >> 1845260

Interobserver variability in the interpretation of brush cytologic studies from head and neck lesions.

M L Nichols1, F B Quinn, V J Schnadig, P Zaharopoulos, J A Hokanson, L Des Jardins, M M McCracken.   

Abstract

A study was conducted to evaluate the usefulness of brush cytology as a diagnostic tool for lesions of the head and neck. Brush specimens were obtained from patients for whom surgical biopsy was recommended by the Otolaryngology Service of the University of Texas Medical Branch Hospitals, Galveston. Specimens were interpreted independently by three cytologists, and interobserver variability was calculated. If a surgical biopsy was performed, histopathologic diagnosis was used as the reference standard to assess the accuracy of each cytologic interpretation. Correspondence of cytopathologic interpretation with histologic diagnosis was sufficient to conclude that brush biopsy is a useful screening technique for unsuspected or clinically undetected malignant tumors of the upper aerodigestive tract. Because of its ability to sample large surface areas with minimal tissue trauma, brush biopsy can be a useful screening technique in combination with selective surgical biopsy for the detection of cytologic changes of malignant neoplasia. Brush cytology costs less than surgical biopsy, yet its relatively high sensitivity and specificity for both benign and malignant grades support its utility. Brush cytology, furthermore, has a low interobserver variability for the benign and malignant grades, suggesting that in the hands of an experienced cytopathologist it can be relied on with confidence. For grades 2 or 3 (inconclusive), brush cytology, however, demonstrated much higher interobserver variability. Based on the findings of this and other studies, brush cytology can be effective in identifying clinically unsuspected malignant tumors of the upper aerodigestive tract, especially in patients with mucosal changes suggestive of "field cancerization."

Entities:  

Mesh:

Year:  1991        PMID: 1845260     DOI: 10.1001/archotol.1991.01870240042006

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

Review 1.  [Oral cytology: historical development, current status, and perspectives].

Authors:  M Hullmann; T E Reichert; R Dahse; F von Eggeling; H Pistner; H Kosmehl; O Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-01

2.  [Identification of a recurrent oral squamous cell carcinoma by brush cytology].

Authors:  Antonios Moralis; Martin Kunkel; Torsten Eugen Reichert; Hartwig Kosmehl; Oliver Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-12

Review 3.  Potential of optical coherence tomography for early diagnosis of oral malignancies.

Authors:  Michael DeCoro; Petra Wilder-Smith
Journal:  Expert Rev Anticancer Ther       Date:  2010-03       Impact factor: 4.512

4.  Efficacy of oral brush cytology in the evaluation of the oral premalignant and malignant lesions.

Authors:  M Babshet; K Nandimath; Sk Pervatikar; Vg Naikmasur
Journal:  J Cytol       Date:  2011-10       Impact factor: 1.000

5.  In vivo diagnosis of oral dysplasia and malignancy using optical coherence tomography: preliminary studies in 50 patients.

Authors:  Petra Wilder-Smith; Kenneth Lee; Shuguang Guo; Jun Zhang; Kathryn Osann; Zhongping Chen; Diana Messadi
Journal:  Lasers Surg Med       Date:  2009-07       Impact factor: 4.025

6.  Toward early diagnosis of oral cancer: Diagnostic utility of cytomorphological features, a pilot study.

Authors:  Zeeba Shamim Jairajpuri; Safia Rana; Apoorva Hajela; Sujata Jetley
Journal:  Natl J Maxillofac Surg       Date:  2019 Jan-Jun

Review 7.  Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions.

Authors:  Ravi Mehrotra; Anurag Gupta; Mamta Singh; Rahela Ibrahim
Journal:  Mol Cancer       Date:  2006-03-23       Impact factor: 27.401

8.  Correlation of clinical, cytological and histological findings in oral squamous cell carcinomas.

Authors:  Michele Cardoso Sousa; Monica Ghislaine Oliveira Alves; Luciano Albino Souza; Adriana Aigotti Haberbeck Brandão; Janete Dias Almeida; Luiz Antonio Guimarães Cabral
Journal:  Oncol Lett       Date:  2014-06-03       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.